secwatch.observer — SEC 8-K summary
======================================

Issuer:     Damora Therapeutics, Inc. (DMRA)
CIK:        0001800315
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0000950170-24-076186
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galecto shareholders approve reverse stock split and elect Anne Prener to board
-------------------------------------------------------------------------------

- Director Anne Prener elected with 10,651,770 for, 711,618 withheld; 5,840,793 broker non-votes.
- Reverse stock split approved (ratio 1:4 to 1:25, board to decide within one year): 15,283,182 for, 1,830,713 against.
- Ratification of EY as auditor for FY2024 passed with 16,927,703 for, 197,148 against.
- Total shares entitled to vote: 27,112,697; 17,204,181 present or represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/0000950170-24-076186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800315/000095017024076186/glto-20240620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-076186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer